/

Stoke Therapeutics

Develops RNA-based therapies for severe genetic disorders.

BiotechnologyHealthcare stoketherapeutics.com ↗

Company facts

Founded: 2014
Employees: 150
Headquarters: United States
Type: Public
Listed: NASDAQ: STOK